Esperion Therapeutics, Inc.ESPRNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$1.53
Net Income/Share$-0.53
Operating CF/Share$-0.47
Free CF/Share$-0.47
Cash/Share$0.47
Book Value/Share$-2.28
Tangible Book/Share$-2.28
Equity/Share$-2.28
Interest Debt/Share$3.43
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$669.63M
Enterprise Value$1.18B
P/E Ratio-6.35P/S Ratio2.20P/OCF Ratio-7.20
P/FCF Ratio-7.18
P/B Ratio-1.49P/TB Ratio-1.49
EV/Sales3.88EV/EBITDA-43.10
Graham Valuation
Graham Number--
Graham Net-Net$-2.84
Profitability
Earnings Yield-15.75%FCF Yield-13.93%ROE24.90%ROIC-18.71%Return on Tangible Assets-29.08%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF0.00%
CapEx/Revenue0.00%
CapEx/Depreciation0.00
SBC/Revenue3.39%
SG&A/Revenue3.76%
R&D/Revenue14.78%
Liquidity & Solvency
Debt/Equity-1.33Debt/Assets1.65Debt/Market Cap0.90
Net Debt/EBITDA-18.60
Current Ratio1.00Interest Coverage-0.37xIncome Quality0.88Efficiency
Days Sales Outstanding143 days
Days Payables Outstanding200 days
Days Inventory367 days
Receivables Turnover2.55x
Payables Turnover1.82x
Inventory Turnover1.00x
Capital Structure
Tangible Assets-$451.42M
Working Capital$1.43M
Invested Capital$4.99M
Intangibles/Assets0.02%